Position in SRRK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,879,386
+$2,246,937 QoQ
Shares Held
119,597
+45.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.83857454618426.ToString("F0")%
None 2.161425453815731.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. SRRK ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in SRRK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,879,386 | 119,597 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,632,449 | 82,462 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,538,686 | 68,171 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,194,763 | 61,964 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,766,223 | 54,937 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $13,491,595 | 312,161 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $179,526 | 22,413 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $183,341 | 22,010 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,714,512 | 96,538 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,772,294 | 307,037 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $103,397 | 14,563 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $93,811 | 12,442 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,696,824 | 212,103 | Shares | Defined | 2023-05-12 | |
| 2022-03-31 | $153,286 | 11,892 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $290,030 | 11,676 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $422,424 | 12,793 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $314,720 | 10,890 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $6,952,932 | 137,247 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $239,786 | 4,941 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 | $451,702 | 37,300 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||